In the present study, GnRH analogues alone exhibited a moderately increased potential in pneumonitis promotion after breast cancer RT, albeit not to a significant level (OR 1.52, 95% CI 0.87–2.67). The gene discussed is GNRH1; the disease is pneumonitis.